Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $256.72 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. | $150.00 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $61.94 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $44.78 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.00 | 1 | NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. ($150.00) |
| 2023 | $19.43 | 1 | GlaxoSmithKline, LLC. ($19.43) |
| 2022 | $48.70 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($35.96) |
| 2019 | $38.59 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($25.98) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/19/2024 | NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. | Hera W10 (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: Ultrasound | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Womens Health | ||||||
| 10/12/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: VACCINES | ||||||
| 09/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Womens Health | ||||||
| 07/15/2019 | Bayer HealthCare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Women's Health | ||||||
| 05/14/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 750 | 2,032 | $202,360 | $58,896 |
| 2022 | 18 | 712 | 2,517 | $233,512 | $64,470 |
| 2021 | 13 | 692 | 1,682 | $176,977 | $53,585 |
| 2020 | 15 | 580 | 2,323 | $148,130 | $43,783 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 263 | $70,803 | $25,461 | 36.0% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 104 | 161 | $39,243 | $14,618 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 81 | $13,133 | $5,057 | 38.5% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2023 | 27 | 566 | $43,632 | $4,265 | 9.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $5,439 | $2,057 | 37.8% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 39 | 54 | $3,953 | $1,251 | 31.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 17 | 21 | $3,396 | $1,224 | 36.1% |
| 20604 | Aspiration and/or injection of fluid from small joint using ultrasound guidance | Office | 2023 | 12 | 19 | $3,618 | $1,070 | 29.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 17 | 18 | $2,412 | $828.71 | 34.4% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 32 | 37 | $2,265 | $735.19 | 32.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 138 | 721 | $8,726 | $581.77 | 6.7% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 14 | 17 | $2,035 | $446.27 | 21.9% |
| 20551 | Injection into tendon at attachment to bone or muscle | Office | 2023 | 11 | 13 | $1,579 | $420.28 | 26.6% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 13 | 13 | $993.00 | $364.08 | 36.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $550.00 | $341.44 | 62.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 13 | 20 | $584.00 | $174.80 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 179 | $36,274 | $16,303 | 44.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 85 | 137 | $29,006 | $11,464 | 39.5% |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 2022 | 29 | 1,180 | $109,200 | $9,324 | 8.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $12,012 | $7,289 | 60.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 102 | $13,923 | $6,469 | 46.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 15 | 15 | $4,425 | $4,179 | 94.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 24 | $6,552 | $3,445 | 52.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 25 | $1,625 | $1,593 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,037 | $785.98 | 75.8% |
About Dr. Zachary Devilbiss, DO
Dr. Zachary Devilbiss, DO is a Family Medicine healthcare provider based in Windsor, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1942615471.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zachary Devilbiss, DO has received a total of $256.72 in payments from pharmaceutical and medical device companies, with $150.00 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($256.72).
As a Medicare-enrolled provider, Devilbiss has provided services to 2,734 Medicare beneficiaries, totaling 8,554 services with total Medicare billing of $220,734. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Sports Medicine
- Location Windsor, CO
- Active Since 06/23/2014
- Last Updated 07/27/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1942615471
Products in Payments
- Hera W10 (Device) $150.00
- Kyleena (Drug) $35.96
- Mirena (Drug) $25.98
- AREXVY (Drug) $19.43
- SHINGRIX (Biological) $12.74
- BEXSERO (Biological) $12.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Windsor
Dr. Timothy Madigan, M.d, M.D
Family Medicine — Payments: $5,549
Dr. Amie Etters, Md, MD
Family Medicine — Payments: $5,518
Neena Pursnani, Md, MD
Family Medicine — Payments: $3,223
Dr. Johnny Wright, M.d., D.p.m, M.D., D.P.M
Family Medicine — Payments: $1,980
Dr. Alicia Albers, Md, MD
Family Medicine — Payments: $1,883
Jennifer Blair, D.o, D.O
Family Medicine — Payments: $1,150